Protalix BioTherapeutics, Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Protalix BioTherapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Protalix BioTherapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 163 %, a 52.2% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 163 -178 -52.2% Sep 30, 2024
Q2 2024 171 -1.23K -87.7% Jun 30, 2024
Q1 2024 149 +1.02K Mar 31, 2024
Q4 2023 192 +903 Dec 31, 2023
Q3 2023 341 +1.18K Sep 30, 2023
Q2 2023 1.4K +2.73K Jun 30, 2023
Q1 2023 -872 +2.75K +75.9% Mar 31, 2023
Q4 2022 -711 -3.55K -125% Dec 31, 2022
Q3 2022 -843 +3.53K +80.7% Sep 30, 2022
Q2 2022 -1.33K -397 -42.5% Jun 30, 2022
Q1 2022 -3.62K -3.13K -639% Mar 31, 2022
Q4 2021 2.84K +3.17K Dec 31, 2021
Q3 2021 -4.37K -4.11K -1577% Sep 30, 2021
Q2 2021 -936 -713 -320% Jun 30, 2021
Q1 2021 -490 -291 -146% Mar 31, 2021
Q4 2020 -334 -154 -85.3% Dec 31, 2020
Q3 2020 -261 -68.8 -35.8% Sep 30, 2020
Q2 2020 -223 -16.1 -7.79% Jun 30, 2020
Q1 2020 -199 +18.8 +8.62% Mar 31, 2020
Q4 2019 -180 +55.8 +23.6% Dec 31, 2019
Q3 2019 -192 +71.5 +27.1% Sep 30, 2019
Q2 2019 -207 +80.2 +28% Jun 30, 2019
Q1 2019 -218 +112 +34.1% Mar 31, 2019
Q4 2018 -236 +46.6 +16.5% Dec 31, 2018
Q3 2018 -264 +55.5 +17.4% Sep 30, 2018
Q2 2018 -287 +61.5 +17.7% Jun 30, 2018
Q1 2018 -330 +68.7 +17.2% Mar 31, 2018
Q4 2017 -283 +867 +75.4% Dec 31, 2017
Q3 2017 -319 +3.28K +91.1% Sep 30, 2017
Q2 2017 -348 +265 +43.2% Jun 30, 2017
Q1 2017 -399 -40.9 -11.4% Mar 31, 2017
Q4 2016 -1.15K -889 -342% Dec 31, 2016
Q3 2016 -3.59K -3.38K -1610% Sep 30, 2016
Q2 2016 -613 -382 -165% Jun 30, 2016
Q1 2016 -358 -95.6 -36.4% Mar 31, 2016
Q4 2015 -260 +45.4 +14.8% Dec 31, 2015
Q3 2015 -210 +159 +43.1% Sep 30, 2015
Q2 2015 -231 +240 +51% Jun 30, 2015
Q1 2015 -262 +286 +52.2% Mar 31, 2015
Q4 2014 -306 +387 +55.9% Dec 31, 2014
Q3 2014 -369 +597 +61.8% Sep 30, 2014
Q2 2014 -471 +1.34K +74% Jun 30, 2014
Q1 2014 -549 -10.8K -105% Mar 31, 2014
Q4 2013 -692 -11.5K -106% Dec 31, 2013
Q3 2013 -966 +550 +36.3% Sep 30, 2013
Q2 2013 -1.81K -1.08K -148% Jun 30, 2013
Q1 2013 10.3K +10.8K Mar 31, 2013
Q4 2012 10.8K Dec 31, 2012
Q3 2012 -1.52K Sep 30, 2012
Q2 2012 -732 Jun 30, 2012
Q1 2012 -532 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.